Figure 3.
Immunohistochemical staining of FFPE tumor tissue samples of NSCLC patients using anti-CB1 and anti-CB2 monoclonal antibodies (under ×10 lens). IHC, immunohistochemistry; CB1, cannabinoid receptor 1; CB2, cannabinoid receptor 2; FFPE, formalin-fixed paraffin-embedded; NSCLC, non-small cell lung cancer.